Tokyo, Japan, April 1, 2026 – Azuriris, Inc. (“Azuriris”), a privately held biotechnology company, today announced the relocation of its head office to Chuo-ku, Tokyo, Japan.
The move places Azuriris in the Nihonbashi life science and innovation district, a leading biotechnology hub supported by LINK-J (Life Science Innovation Network Japan), and reflects the company’s continued growth and commitment to advancing biomedical research and innovation.
“We are excited to announce this important step for Azuriris,” said Yusuke Tominari, Ph.D., Co-Founder and Chief Executive Officer of Azuriris. “By joining the Nihonbashi life science ecosystem, we are strengthening our platform for collaboration and innovation as we pursue a future where science and imagination converge to improve health and well-being worldwide.”
New head office
Nihonbashi Life Science Building7
1-9-10, Nihonbashi Horidomecho, Chuo-ku, Tokyo 103-0012, Japan
###
Media and Investor Contact:
Azuriris, Inc.
1-9-10, Nihonbashi Horidomecho, Chuo-ku, Tokyo 103-0012, Japan
E-mail：info@azuriris.com
